Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study
Copyright policy )Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study
The World Health Organization launched a global initiative, known as aDSM (active TB drug safety monitoring and management) to better describe the safety profile of new treatment regimens for drug-resistant tuberculosis (TB) in real-world settings. However, comprehensive surveillance is difficult to implement in several countries. The aim of the aDSM project is to demonstrate the feasibility of implementing national aDSM registers and to describe the type and the frequency of adverse events (AEs) associated with exposure to the new anti-TB drugs. Following a pilot study carried out in 2016, official involvement of TB reference centres/countries into the project was sought and cases treated with bedaquiline- and/or delamanid-containing regimens were consecutively recruited. AEs were prospectively collected ensuring potential attribution of the AE to a specific drug based on its known safety profile. A total of 309 cases were fully reported from 41 centres in 27 countries (65% males; 268 treated with bedaquiline, 20 with delamanid, and 21 with both drugs) out of an estimated 781 cases the participating countries had committed to report by the first quarter of 2019.
- Ministry of Health Malaysia
- Oswaldo Cruz Foundation Brazil
- Queen Mary University of London United Kingdom
- Université Libre de Bruxelles Belgium
- University of Sydney Australia
Microbiologie et protistologie [parasitologie hum. et anim.], Male, Monitoring, Bedaquiline, Antitubercular Agents, 610, MDR-TB, Pilot Projects, Infectious and parasitic diseases, RC109-216, adverse events ; bedaquiline ; delamanid ; MDR-TB ; monitoring ; tuberculosis, World Health Organization, Adverse events; Bedaquiline; Delamanid; MDR-TB; Monitoring; Tuberculosis; Antitubercular Agents; Diarylquinolines; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Male; Nitroimidazoles; Oxazoles; Pilot Projects; Tuberculosis; Tuberculosis, Multidrug-Resistant; World Health Organization, 616, Tuberculosis, Multidrug-Resistant, Humans, Tuberculosis, Diarylquinolines, Pathologie maladies infectieuses, Oxazoles, Adverse events; Bedaquiline; Delamanid; MDR-TB; Monitoring; Tuberculosis, Microbiologie et protistologie [entomologie,phytoparasitolog.], RA Aspectos Públicos de la Medicina, Nitroimidazoles, Adverse events, Feasibility Studies, Drug Therapy, Combination, Female, Delamanid, Microbiologie et protistologie [bacteriol.virolog.mycolog.], Radboudumc 4: lnfectious Diseases and Global Health RIHS: Radboud Institute for Health Sciences, Pulmonary Diseases - Radboud University Medical Center
Microbiologie et protistologie [parasitologie hum. et anim.], Male, Monitoring, Bedaquiline, Antitubercular Agents, 610, MDR-TB, Pilot Projects, Infectious and parasitic diseases, RC109-216, adverse events ; bedaquiline ; delamanid ; MDR-TB ; monitoring ; tuberculosis, World Health Organization, Adverse events; Bedaquiline; Delamanid; MDR-TB; Monitoring; Tuberculosis; Antitubercular Agents; Diarylquinolines; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Male; Nitroimidazoles; Oxazoles; Pilot Projects; Tuberculosis; Tuberculosis, Multidrug-Resistant; World Health Organization, 616, Tuberculosis, Multidrug-Resistant, Humans, Tuberculosis, Diarylquinolines, Pathologie maladies infectieuses, Oxazoles, Adverse events; Bedaquiline; Delamanid; MDR-TB; Monitoring; Tuberculosis, Microbiologie et protistologie [entomologie,phytoparasitolog.], RA Aspectos Públicos de la Medicina, Nitroimidazoles, Adverse events, Feasibility Studies, Drug Therapy, Combination, Female, Delamanid, Microbiologie et protistologie [bacteriol.virolog.mycolog.], Radboudumc 4: lnfectious Diseases and Global Health RIHS: Radboud Institute for Health Sciences, Pulmonary Diseases - Radboud University Medical Center
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).45 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 1%
Citations provided by BIP!Popularity provided by BIP!